Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$73.71BHealthcare Market cap, Sector
UCB SA
UCB.BR$45.13BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 UCB.BR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsUCB.BR
84B
C62
87A
B73
92A
B74
66C
D54
75B
D50
91A
D52
95A
D56
Side-by-side metrics
| Metric | JSLL.NS | UCB.BR |
|---|---|---|
| Market cap | Winner: $73.71B | $45.13B |
| P/E (TTM) | 33.3x | 33.1x Winner |
| EV/EBIT | Winner: 24.1x | 26.5x |
| ROIC (TTM) | Winner: 39.15% | 11.15% |
| Gross margin | Winner: 88.58% | 74.29% |
| Net margin | Winner: 27.68% | 20.13% |
| Revenue CAGR 5y | Winner: 57.81% | 11.95% |
| EPS CAGR 5y | 86.67% | 93.38% Winner |
| Debt / Equity | 0.3x | 0.2x Winner |
| Dividend yield | - | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Revenue CAGR 5y57.81%vs 11.95%+79%
- ROIC (TTM)39.15%vs 11.15%+72%
- Market cap$73.71Bvs $45.13B+39%
- Net margin27.68%vs 20.13%+27%
UCB.BR leads on
- Debt / Equity0.2xvs 0.3x+24%
- EPS CAGR 5y93.38%vs 86.67%+7%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.